LENASTER 3.35 mg/ml, eye drop solution in a single-dose container 30 single-dose containers of 0.3 ml
Active ingredients: Hydrocortisone sodium phosphate
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solution30 single-dose containers of 0.3 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LENASTER 3,35 mg/mL, collyre en solution en récipient unidose
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 30 récipient(s) unidose(s) polyéthylène basse densité (PEBD) de 0,3 mL suremballée(s)/surpochée(s)
- Marketing authorisation holder
- HORUS PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Apr 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67016677CIP73032350CIP133400930323502Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE SODIQUE D'HYDROCORTISONEcollyre | 3,35 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.